aHSP anticorps (HRP)

N° du produit ABIN1421062

Cet anticorps Lapin Polyclonal détecte spécifiquement aHSP dans WB et IHC (p). Il présente une réactivité envers Humain.

Aperçu rapide pour aHSP anticorps (HRP) (ABIN1421062)

Antigène: aHSP (alpha Hemoglobin Stabilizing Protein (aHSP))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp aHSP est conjugé à/à la HRP

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Détail du produit anti-aHSP anticorps (HRP)

Réactivité croisée: Humain

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human AHSP/ERAF

Isotype: IgG

Information d'application

Indications d'application: WB 1:300-5000
IHC-P 1:200-400

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Conseil sur la manipulation: Do NOT add Sodium Azide! Use of Sodium Azide will inhibit enzyme activity of horseradish peroxidase.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur aHSP

Antigène: aHSP (alpha Hemoglobin Stabilizing Protein (aHSP))

Autre désignation: AHSP

Sujet:

Synonyms: AHSP, AHSP_HUMAN, Alpha hemoglobin stabilizing protein, Alpha-hemoglobin-stabilizing protein, EDRF, ERAF, Erythroid associated factor, Erythroid dferentiation associated factor, Erythroid dferentiation related factor, Erythroid dferentiation-related factor, Erythroid-associated factor.

Background: Act as a chaperone to prevent the harmful aggregation of alpha-hemoglobin during normal erythroid cell development. Specifically protects free alpha-hemoglobin from precipitation. It is predicted to modulate pathological states of alpha-hemoglobin excess such as beta-thalassemia.